论文信息 - Risk Mitigation Strategy for Concizumab Clinical Trials after Pause Due to Non-Fatal Thrombotic Events - 字舞流文

Risk Mitigation Strategy for Concizumab Clinical Trials after Pause Due to Non-Fatal Thrombotic Events

Trine Høyer Rose | S. Seremetis | S. Tamer | J. Haaning | T. Porstmann | Katarina Cepo | Josephine Skovgaard Rasmussen | Trine Høyer Rose | S. C. Tamer | J. S. Rasmussen